Study of telomere length and different markers of oxidative stress in patients with Parkinson's disease

Journal of Nutrition, Health and Aging

Volumn 15, Issue 4, 2011, Pages 277-281

  Watfa, G ^a,b   Dragonas, C ^c,d   Brosche, T ^d   Dittrich, R ^e   Sieber, C C ^c,d   Alecu, C ^a   Benetos, Athanase ^a,b   Nzietchueng, R ^b  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b INSERM   (France)

^c Nuremberg Clinic Center   (Germany)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^e UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Aging; oxidative stress; Parkinson's disease; telomere length

Indexed keywords

ACETYLSALICYLIC ACID; AMANTADINE; CATECHOL METHYLTRANSFERASE INHIBITOR; GLUTATHIONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LEVODOPA; MONOAMINE OXIDASE INHIBITOR; SUPEROXIDE DISMUTASE;

AGED; AGING; ARTICLE; CASE CONTROL STUDY; CHROMOSOME SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; ENZYME ACTIVITY; FEMALE; HUMAN; LEUKOCYTE; MALE; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REGULATORY MECHANISM; SOUTHERN BLOTTING; TELOMERE;

EID: 79954420408     PISSN: 12797707     EISSN: 17604788     Source Type: Journal    
DOI: 10.1007/s12603-010-0275-7     Document Type: Article

References (36)

1. C.B. Harley 1991 Telomere loss: mitotic clock or genetic time bomb? Mutat Res 256 271 282 1722017 1:CAS:528:DyaK38Xls1SisQ%3D%3D
2. A. Aviv 2004 Telomeres and human aging: facts and fibs Sci Aging Knowledge Environ 2004 pe43 15618136 10.1126/sageke.2004.51.pe43
3. V. Cattan N. Mercier J.P. Gardner, et al. 2008 Chronic oxidative stress induces a tissuespecific reduction in telomere length in CAST/Ei mice Free Radic Biol Med 44 1592 1598 18249196 10.1016/j.freeradbiomed.2008.01.007 1:CAS:528:DC%2BD1cXktlGlsL4%3D
4. C. Matthews I. Gorenne S. Scott, et al. 2006 Vascular smooth muscle cells undergo telomere-based senescence in human atherosclerosis: effects of telomerase and oxidative stress Circ Res 99 156 164 16794190 10.1161/01.RES.0000233315.38086.bc 1:CAS:528:DC%2BD28XmvFaltbg%3D (Pubitemid 44297039)
5. T. von Zglinicki 2002 Oxidative stress shortens telomeres Trends Biochem Sci 27 339 344 10.1016/S0968-0004(02)02110-2 (Pubitemid 34756516)
6. E. Chang C.B. Harley 1995 Telomere length and replicative aging in human vascular tissues Proc Natl Acad Sci U S A 92 11190 11194 7479963 10.1073/pnas.92.24.11190 1:CAS:528:DyaK2MXps1altrs%3D
7. A. Benetos J.P. Gardner M. Zureik, et al. 2004 Short telomeres are associated with increased carotid atherosclerosis in hypertensive subjects Hypertension 43 182 185 14732735 10.1161/01.HYP.0000113081.42868.f4 1:CAS:528:DC%2BD2cXlvFeiuw%3D%3D (Pubitemid 38174171)
8. A. Benetos K. Okuda M. Lajemi, et al. 2001 Telomere length as an indicator of biological aging: the gender effect and relation with pulse pressure and pulse wave velocity Hypertension 37 381 385 1:CAS:528: DC%2BD3MXhvVSht70%3D (Pubitemid 32198997)
9. E. Jeanclos N.J. Schork K.O. Kyvik M. Kimura J.H. Skurnick A. Aviv 2000 Telomere length inversely correlates with pulse pressure and is highly familial Hypertension 36 195 200 10948077 1:CAS:528:DC%2BD3cXmtlers7k%3D (Pubitemid 30626988)
10. L.A. Panossian V.R. Porter H.F. Valenzuela, et al. 2003 Telomere shortening in T cells correlates with Alzheimer's disease status Neurobiol Aging 24 77 84 12493553 10.1016/S0197-4580(02)00043-X 1:CAS:528:DC%2BD38XpsFWht7g%3D (Pubitemid 35454145)
11. N.J. Samani R. Boultby R. Butler J.R. Thompson A.H. Goodall 2001 Telomere shortening in atherosclerosis Lancet 358 472 473 11513915 10.1016/S0140- 6736(01)05633-1 1:CAS:528:DC%2BD3MXmtV2ht7o%3D (Pubitemid 32769858)
12. D.T. Dexter A.E. Holley W.D. Flitter, et al. 1994 Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study Mov Disord 9 92 97 8139611 10.1002/mds.870090115 1:STN:280:DyaK2c7oslOruw%3D%3D (Pubitemid 24022621)
13. P. Jenner C.W. Olanow 1996 Oxidative stress and the pathogenesis of Parkinson's disease Neurology 47 S161 170 8959985 1:STN:280:DyaK2s7hvFWlsA%3D%3D
14. H. Wang H. Chen X. Gao, et al. 2008 Telomere length and risk of Parkinson's disease Mov Disord 23 302 305 18044760 10.1002/mds.21867 (Pubitemid 351311569)
15. J.Z. Guan T. Maeda M. Sugano, et al. 2008 A percentage analysis of the telomere length in Parkinson's disease patients J Gerontol A Biol Sci Med Sci 63 467 473 18511749
16. C. Dragonas T. Bertsch C.C. Sieber T. Brosche 2009 Plasmalogens as a marker of elevated systemic oxidative stress in Parkinson's disease Clin Chem Lab Med 47 894 897 19575554 10.1515/CCLM.2009.205 1:CAS:528:DC%2BD1MXpsFOkt78%3D
17. W.B. Ershler 2001 The value of the SENIEUR protocol: distinction between "ideal aging" and clinical reality Mech Ageing Dev 122 134 136 11166352 10.1016/S0047-6374(00)00241-4 1:STN:280:DC%2BD3M3lvVanug%3D%3D (Pubitemid 32144822)
18. S.A. Miller D.D. Dykes H.F. Polesky 1988 A simple salting out procedure for extracting DNA from human nucleated cells Nucleic Acids Res 16 1215 3344216 10.1093/nar/16.3.1215 1:CAS:528:DyaL1cXhsVKlsrs%3D
19. N. Tentolouris R. Nzietchueng V. Cattan, et al. 2007 White blood cells telomere length is shorter in males with type 2 diabetes and microalbuminuria Diabetes Care 30 2909 2915 17666463 10.2337/dc07-0633 1:CAS:528: DC%2BD2sXhtlKhs7vJ (Pubitemid 350089752)
20. C. Martin-Ruiz H.O. Dickinson B. Keys E. Rowan R.A. Kenny T. Von Zglinicki 2006 Telomere length predicts poststroke mortality, dementia, and cognitive decline Ann Neurol 60 174 180 16685698 10.1002/ana.20869 (Pubitemid 44182392)
21. N. Lev E. Melamed D. Offen 2003 Apoptosis and Parkinson's disease Prog Neuropsychopharmacol Biol Psychiatry 27 245 250 12657363 10.1016/S0278-5846(03) 00019-8 1:CAS:528:DC%2BD3sXit12ntr0%3D (Pubitemid 36351491)
22. T.S. Nawrot J.A. Staessen J.P. Gardner A. Aviv 2004 Telomere length and possible link to X chromosome Lancet 363 507 510 14975611 10.1016/S0140-6736(04) 15535-9 1:CAS:528:DC%2BD2cXht1Kgtrs%3D (Pubitemid 38229449)
23. K.J. Barnham C.L. Masters A.I. Bush 2004 Neurodegenerative diseases and oxidative stress Nat Rev Drug Discov 3 205 214 15031734 10.1038/nrd1330 1:CAS:528:DC%2BD2cXit12nsL4%3D
24. A. Prigione B. Begni A. Galbussera, et al. 2006 Oxidative stress in peripheral blood mononuclear cells from patients with Parkinson's disease: negative correlation with levodopa dosage Neurobiol Dis 23 36 43 16563783 10.1016/j.nbd.2006.01.013 1:CAS:528:DC%2BD28XlvFyqtL8%3D (Pubitemid 43903629)
25. A. Prigione I.U. Isaias A. Galbussera, et al. 2009 Increased oxidative stress in lymphocytes from untreated Parkinson's disease patients Parkinsonism Relat Disord 15 327 328 18640066 10.1016/j.parkreldis.2008.05.013
26. J.A. Serra R.O. Dominguez E.S. de Lustig, et al. 2001 Parkinson's disease is associated with oxidative stress: comparison of peripheral antioxidant profiles in living Parkinson's, Alzheimer's and vascular dementia patients J Neural Transm 108 1135 1148 11725816 10.1007/s007020170003 1:CAS:528: DC%2BD38XjvVSjtg%3D%3D (Pubitemid 33022763)
27. S. Younes-Mhenni M. Frih-Ayed A. Kerkeni M. Bost G. Chazot 2007 Peripheral blood markers of oxidative stress in Parkinson's disease Eur Neurol 58 78 83 17565220 1:CAS:528:DC%2BD2sXhtVenur3E (Pubitemid 47237650)
28. H.L. Martin P. Teismann 2009 Glutathione-a review on its role and significance in Parkinson's disease FASEB J 23 3263 3272 19542204 10.1096/fj.08-125443 1:CAS:528:DC%2BD1MXht1GjtLnO
29. Z.I. Alam S.E. Daniel A.J. Lees D.C. Marsden P. Jenner B. Halliwell 1997 A generalised increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease J Neurochem 69 1326 1329 9282961 10.1046/j.1471-4159.1997.69031326.x 1:CAS:528:DyaK2sXls1Chu70%3D (Pubitemid 27364859)
30. K. Sudha A.V. Rao S. Rao A. Rao 2003 Free radical toxicity and antioxidants in Parkinson's disease Neurol India 51 60 62 12865518 1:STN:280:DC%2BD3szjtlClsQ%3D%3D (Pubitemid 36908854)
31. P.A. Kocaturk M.C. Akbostanci F. Tan G.O. Kavas 2000 Superoxide dismutase activity and zinc and copper concentrations in Parkinson's disease Pathophysiology 7 63 67 10825687 10.1016/S0928-4680(00)00030-4 1:CAS:528:DC%2BD3cXksFSgtr0%3D (Pubitemid 30313000)
32. S. Abraham C.C. Soundararajan S. Vivekanandhan M. Behari 2005 Erythrocyte antioxidant enzymes in Parkinson's disease Indian J Med Res 121 111 115 15756044 1:CAS:528:DC%2BD2MXjtFensLY%3D (Pubitemid 40403244)
33. S. Bostantjopoulou G. Kyriazis Z. Katsarou G. Kiosseoglou A. Kazis G. Mentenopoulos 1997 Superoxide dismutase activity in early and advanced Parkinson's disease Funct Neurol 12 63 68 9238339 1:STN:280:DyaK2szotV2rsA%3D%3D (Pubitemid 27244753)
34. Y. Ihara M. Chuda S. Kuroda T. Hayabara 1999 Hydroxyl radical and superoxide dismutase in blood of patients with Parkinson's disease: relationship to clinical data J Neurol Sci 170 90 95 10561523 10.1016/S0022-510X(99)00192-6 1:CAS:528:DyaK1MXotV2nsb8%3D (Pubitemid 29528530)
35. D.J. Kurz S. Decary Y. Hong E. Trivier A. Akhmedov J.D. Erusalimsky 2004 Chronic oxidative stress compromises telomere integrity and accelerates the onset of senescence in human endothelial cells J Cell Sci 117 2417 2426 15126641 10.1242/jcs.01097 1:CAS:528:DC%2BD2cXlt1OisLk%3D (Pubitemid 38807508)
36. T. De Meyer E.R. Rietzschel M.L. De Buyzere W. Van Criekinge S. Bekaert 2008 Studying telomeres in a longitudinal population based study Front Biosci 13 2960 2970 17981769 10.2741/2901 (Pubitemid 351589212)